Human Serum Albumin (HSA) accounts for 60% of the total protein in blood serum and it is the most widely used intravenous protein in a number of human therapies. HSA, however, is currently extracted only from blood because of a lack of commercially feasible recombinant expression systems. HSA is highly susceptible to proteolytic degradation in recombinant systems and is expensive to purify. Expression of HSA in transgenic chloroplasts using Shine-Dalgarno sequence (SD), which usually facilitates hyper-expression of transgenes, resulted only in 0.02% HSA in total protein (tp). Modification of HSA regulatory sequences using chloroplast untranslated regions (UTRs) resulted in hyper-expression of HSA (up to 11.1% tp), compensating for excessive proteolytic degradation. This is the highest expression of a pharmaceutical protein in transgenic plants and 500-fold greater than previous reports on HSA expression in transgenic leaves. Electron micrographs of immunogold labelled transgenic chloroplasts revealed HSA inclusion bodies, which provided a simple method for purification from other cellular proteins. HSA inclusion bodies could be readily solubilized to obtain a monomeric form using appropriate reagents. The regulatory elements used in this study should serve as a model system for enhancing expression of foreign proteins that are highly susceptible to proteolytic degradation and provide advantages in purification, when inclusion bodies are formed.
Introduction
Availability of recombinant human proteins has revolutionized the use of therapeutically valuable proteins in clinical medicine.
Plants offer a suitable alternative to microbial or animal expression of biopharmaceutical proteins because of their inexpensive production costs and absence of human pathogens. However, there are some limitations. In particular, expression of human proteins in nuclear transgenic plants has been disappointingly low, e.g. human serum albumin 0.02% of total soluble protein (tsp), human Interferon-β 0.000017% of fresh weight, human epidermal growth factor 0.001% of tsp and erythropoietin 0.0026% of tsp (Daniell et al ., 2001d) . Therefore, it is important to increase levels of expression in order to exploit plant production of pharmacologically important proteins.
As an alternative to nuclear expression, the chloroplast transgenic approach has been developed as an effective tool for the expression of biopharmaceutical proteins in plants (Daniell and Dhingra, 2002; Daniell et al ., 2001a,b; DeGray et al ., 2001; Guda et al ., 2000; Staub et al ., 2000) . After the first demonstration of a protein based polymer expression with varied medical applications (Guda et al ., 2000) , transgenic chloroplasts have been shown to express very small antimicrobial peptides without fusion proteins (DeGray et al ., 2001) , assemble functional oligomers with disulphide bonds of the cholera toxin β -subunit (Daniell et al ., 2001b) , and express a monoclonal antibody with coordinated expression and assembly of heavy and light chain with proper folding and formation of disulphide bridges (Daniell et al ., 2001a) , suggesting that adequate redox environment or required chaperonins are present within chloroplasts. Expression of functional human somatotropin in transgenic tobacco chloroplasts established that chloroplasts are capable of proper folding of human proteins with disulphide bonds (Staub et al ., 2000) . The ability to express multiple genes in a single transformation event (Daniell and Dhingra, 2002; De Cosa et al ., 2001) , accumulation of exceptionally large quantities of foreign proteins (De Cosa et al ., 2001) , successful engineering of tomato chromoplasts for high level transgene expression in fruits (Ruf et al ., 2001 ), coupled to hyperexpression of vaccine antigens (Daniell et al ., 2001b) , and the use of plant derived antibiotic free selectable markers (Daniell et al ., 2001c) , augur well for oral delivery of edible vaccines and biopharmaceuticals that are currently beyond the reach of those who need them most. In addition, chloroplast genetic engineering is an environmentally friendly approach, offering containment of transgenes and a solution to gene silencing and position effect encountered in nuclear transgenic plants (Bogorad, 2000; Daniell and Dhingra, 2002; Daniell, 2002) .
HSA is the most widely used intravenous protein and is prescribed in multigram quantities to replace blood volume in trauma and in various other clinical situations (Peters, 1995) .
HSA is a monomeric globular prepro-protein whose mature form consists of a single polypeptide chain of 585 amino acids (66.5 kDa with 17 disulphide bonds). The annual world need exceeds 500 tons, representing a market value of more than $1.5 billion. To date, albumin has been produced primarily by the fractionation of blood serum. Lack of glycosylation facilitates production of functional HSA in prokaryotic systems. Although the HSA gene and cDNA have been expressed in a wide variety of microbial systems, including E. coli (Latta et al ., 1987) , Bacillus subtilis (Saunders et al ., 1987) , Saccharomyces cerevisiae (Quirk et al ., 1989) , Kluyveromyces (Fleer et al ., 1991) or Pichia pastoris (Ohtani et al ., 1998) , no system is yet commercially feasible. Sijmons et al . (1990) made the first reported attempt to express HSA in transgenic plants, but very low expression levels were attained (0.02% tsp). HSA could not be detected if expressed in the cytoplasm, suggesting that the protein is not stable in this compartment, due to high susceptibility to proteolytic degradation. A 10-fold increase in HSA accumulation has been reported recently by nuclear transformation of potato plants and targeting the HSA to the tuber apoplast (Farran et al ., 2002) . Estimates by industry, however, suggest that the cost-effective yield for pharmaceutical production is 0.1 mg of HSA per gram of fresh weight (Farran et al ., 2002) .
In addition, good recombinant systems are still not available for many human proteins that are expensive to purify or highly susceptible to proteolytic degradation. It is known that traditional purification of biopharmaceuticals using columns accounts for 30% of the production cost and 70% of the set up cost (Petrides et al ., 1995) . Proteolytic degradation is another serious concern for industrial bioprocessing. The increasing production of proteins in heterologous hosts through the use of recombinant DNA technology has brought this problem into focus; heterologous proteins appear to be more prone to proteolysis (Enfors, 1992) . Recombinant proteins are often regarded by a cell as foreign and therefore degraded much faster than most endogenous proteins (Rozkov et al ., 2000) . Proteolytic stability of recombinant proteins is a significant factor influencing the final yield.
This study attempts to develop a more efficient method of recombinant HSA production, which may be used as a model system to enrich or purify biopharmaceutical proteins from transgenic plants, which are highly susceptible to proteolytic degradation.
Results and discussion
Two chloroplast transformation vectors were designed with different 5 ′ regulatory sequences to direct HSA expression and maximize protein accumulation in transgenic chloroplasts. Basic pLD vector, developed in this laboratory for chloroplast transformation, was used (Daniell et al ., 1998; Daniell et al ., 2001b; De Cosa et al ., 2001; Guda et al ., 2000; Kota et al ., 1999) . In the plasmid pLDAsdHSA (Figure 1a ), the aadA gene, which confers spectinomycin resistance, and the HSA gene are expressed as a polycistron from the plastid Prrn promoter. The Shine-Dalgarno (SD) consensus sequence GGAGG was placed upstream of both genes. High levels of foreign protein expression in chloroplasts (3-21% of tsp) have been shown for different proteins using this 5 ′ sequence (Daniell et al ., 2001b; DeGray et al ., 2001; Kota et al ., 1999) .
In the pLDApsbAHSA vector (Figure 1a) , the 204 bp tobacco chloroplast DNA fragment containing the promoter and the psbA 5 ′ UTR was inserted immediately upstream of the HSA coding sequence and downstream of the aadA gene. It is well known that foreign genes under the control of the psbA promoter and untranslated region are expressed at very high levels (Daniell et al ., 1990) . This enhancement of translation may be due to elements in the 5 ′ UTR (Eibl et al ., 1999) . Vectors were bombarded into tobacco leaves as described previously (Daniell, 1997) and, after 5 weeks, several primary shoots appeared from each bombarded leaf as a result of independent transformation events. Putative transformed shoots were identified by growth on 500 µ g/mL of spectinomycin.
Integration of the foreign gene cassettes into the chloro- Kota et al ., 1999) , demonstrating that high protein expression levels can be achieved by using this construct in an operon with a SD sequence. Thus, low levels of HSA expression in the pLDAsdHSA transgenic plants could not be due to the effect of regulatory signals in the construct. Differences in the amounts of HSA could be due to post-transcriptional, translational or post-translational effects. To study differences in HSA expression, transcript abundance was examined by Northern blots, which were performed using the 3 ′ psbA region as the probe (Figure 2 ). The 5 ′ psbA/HSA monocistron transcript is much more abundant than the aadA/SD/HSA dicistron, but such differences do not show a linear correlation with the 360-fold difference in HSA accumulation between both transgenic lines. Such a lack of correlation between transcript abundance and protein accumulation has been reported from several laboratories when the psbA 5 ′ UTR is used (Mayfield et al ., 1995; Maliga, 1993, 1994) , suggesting an important role of the psbA 5 ′ UTR in enhancement of translation. Eibl et al . (1999) also showed that deletion of the terminal sequences of the psbA 5 ′ UTR decreased the ability of the UTR to enhance translation. Thus, efficient translation in the pLDApsbAHSA transgenic line might be an important factor in establishing high levels of HSA accumulation.
There are several studies demonstrating that psbA 5 ′ UTR confers light-dependent translation not only to the psbA gene (Zerges, 2000) but also to other heterologous proteins (Eibl et al ., 1999; Maliga, 1993, 1994) . Expression of HSA under the psbA 5 ′ UTR control is therefore expected to be light dependent. Changes in HSA accumulation after different periods of illumination were monitored by ELISA (Figure 3b ). HSA quantity was observed to be maximum up to 50 h of continuous illumination (11.1% of tp) in mature leaves and a 2-4-fold decrease was observed after the 8 h dark period. Such differences in HSA accumulation were so pronounced that it was detected by staining gels with Coomassie Brilliant Blue (Figure 3c ). Maliga (1993, 1994) and Eibl et al. (1999) showed that although translation is arrested in the dark, the 5′psbA/uidA mRNA turnover was very low. This observation was confirmed for HSA by Northern blot analysis, which showed no major differences between light and dark amount of 5′psbA/HSA transcripts (Figure 2, lanes 3, 4) . Therefore, differences in HSA accumulation between dark and light could not be due to differences Ketchner et al. (1995) . It is widely known that protein aggregation into inclusion bodies mostly involves intermolecular associations of partially folded intermediates (Mitraki and King, 1989) . High protein concentrations usually lead to conditions that frequently exceed the normal solubility limit. Even the most abundant protein in photosynthetic cells, RuBisCO, forms inclusion bodies in some cases. Many autotrophic bacteria and all cyanobacteria package much of the RuBisCO into inclusion bodies actively involved in the fixation of CO 2 , known as carboxysomes (Shively and English, 1991). Our hypothesis, based on the process of formation of inclusion bodies, is that in contrast to pLDAsdHSA transgenic lines, HSA synthesized under the psbA 5′UTR forms large aggregates mainly due to the high local concentration of the protein.
Formation of inclusion bodies is one of the strategies for reducing the proteolysis of unstable recombinant proteins (Enfors, 1992) . The majority of recombinant proteins studied have been shown to be highly resistant to proteolysis inside inclusion bodies. Although there is protection from proteases within inclusion bodies, some proteolysis can also take place directly on the aggregated protein (Carrio et al., 1999) . HSA also appears to be susceptible to some proteolytic degradation within transgenic chloroplasts. However, the net balance between synthesis and degradation is highly favourable, especially after several hours of continuous illumination.
Properly folded HSA can be recovered from inclusion bodies after denaturation for complete solubilization and in vitro refolding. Proper refolding of HSA from inclusion bodies is a routine procedure that has been previously demonstrated in several studies with E. coli (Latta et al. (1987) and Saccharomyces cerevisiae (Dodsworth et al., 1996; Quirk et al., 1989) .
In these cases, human and recombinant refolded HSA were compared and it was shown that the two proteins were structurally equivalent, demonstrating that HSA may be recovered from inclusion bodies and properly folded. Following the guidelines from these protocols, HSA was extracted from transgenic chloroplasts. Figure 6a One of the primary goals of this study was to develop a more efficient expression system for human serum albumin, an important human therapeutic protein that is highly susceptible to degradation. Expression of HSA in mature plants under the translational control of SD sequence resulted in very low levels of HSA accumulation, probably due to excessive proteolytic degradation and poor rates of translation.
However, when expressed under the control of psbA promoter and 5′UTR, up to a 500-fold increase in HSA accumulation was observed in mature plants compared to other regulatory sequences tested. HSA was observed to form large inclusion bodies, resulting even in a noticeable increase in the size of transgenic chloroplasts and presumably offering protection to HSA from proteolytic degradation. Inclusion bodies facilitated purification of HSA from other cellular proteins.
The HSA molecule has a chemical and structural function rather than an enzymatic activity, therefore complex studies are necessary to fully demonstrate the functionality of the molecule (see Dodsworth et al., 1996; Ohtani et al., 1998; Petersen et al., 2000; Tarelli et al., 1998; 
Experimental procedures
Chloroplast expression vectors pLDAsdHSA was constructed by inserting the HSA 1.8 kb EcoRI /NotI fragment into the multiple cloning site of the pLD vector (Daniell et al., 1998; Daniell et al., 2001b; De Cosa et al., 2001; Guda et al., 2000; Kota et al., 1999) . This fragment contains the mature HSA coding sequence preceded by a Shine-Dalgarno (GGAGG) and it has an ATG as the initiation codon. These sequences were introduced by using the primer: 5′-GGAGGCAACCATGGATGCACACAAGAGTGAAGG-3′. For the pLDApsbAHSA vector, the 204 bp sequence including the promoter and the psbA 5′UTR, was amplified by PCR using tobacco DNA as template. The following primers were used: 5′-CCGTCGACGTAGAGAAGTCCGTAT T-3′ and 5′-GCCCAT-GGTAAAATCT TGGT T TAT T TA-3′. The fusion with the HSA gene was made at the NcoI site placed at the 3′ end of the psbA 5′UTR and then inserted into the pLD vector as a EcoRI/ NotI fragment. Before proceeding with the bombardment, vectors were tested by Western blot analysis in E. coli.
Bombardment and regeneration
Sterile tobacco (cv. Petit Havana) leaves were bombarded using the Bio-Rad PDS-1000/He biolistic device as described previously (Daniell, 1997) . Bombarded leaves were subjected to two rounds of selection on the RMOP medium containing 500 µg/mL of spectinomycin to regenerate transformants (Daniell, 1997) . After regeneration, plants were rooted on 500 µg/mL of spectinomycin (Daniell et al., 2001b) and transferred to pots in growth chambers. Photoperiod was 16 h light and 8 h dark.
PCR and Southern blot analysis
PCR was used to analyse integration of different cassettes in the transformed plants as described (Daniell et al., 2001b,c; De Cosa et al., 2001; Kota et al., 1999) 
HSA quantification
The ELISA Human Albumin Quantification Kit (Bethyl Laboratories) was used. Transformed and untransformed leaves (100 mg) from potted plants grown under a 16 h photoperiod were ground in liquid nitrogen, resuspended in 700 µL of 50 mM NaOH and analysed following the manufacturer's protocol. Transgenic leaf extracts were diluted to fit in the linear range of the provided HSA standard. Absorbance was read at 450 nm. The DC protein assay (Bio-Rad) was used to determine total solubilized protein.
SDS-PAGE and immunoblot analysis
Transformed and untransformed leaves (100 mg) were ground in liquid nitrogen and resuspended in 200 µL of protein extraction buffer (200 mM Tris-HCl pH 8.0, 100 mM NaCl, 400 mM Sucrose, 14 mM βME, 0.05% Tween20, 0.1% SDS, 10 mM EDTA, 2 mM PMSF). Leaf extracts were boiled in sample buffer (Bio-Rad) and electrophoresed in a 10% polyacrylamide gel. Separated proteins were stained with Coomassie Brilliant Blue G-250 or transferred to a nitrocellulose membrane for immunoblotting. The primary antibody (rabbit anti-HSA, Nordic Immunology) was used at 1 : 10 000 dilution, and the secondary antibody (alkaline phosphatase conjugated mouse antirabbit, Sigma or goat antirabbit HRP conjugated, Southern Biotechnology) at 1 : 15 000. Alkaline phosphatase colour development reagents, BCIP/NBT, in AP Color Development Buffer (Bio-Rad) or the ECL kit (Amersham) were used for detection.
Solubilization of inclusion bodies
Soluble proteins were removed with a first extraction in 0.2 X-100. After centrifugation for 60 min at 20 000 g, the pellet was solubilized for 16 h at 4 °C in 6 M Gu-HCl, 0.1 M βME and 0.25 mM Tris-HCl pH 7.4. After centrifugation for 60 min at 20 000 g, the supernatant was then slowly diluted 100-fold in 100 mM NaCl, 50 mM Tris-HCl pH 8.5 and 1 mM EDTA for 24 h at 4 °C. Fractions were electrophoresed in a SDS-PAGE 10% gel and silver stained with Bio-Rad reagents and protocol.
Transmission electron microscopy and immunogold labelling Seedlings and mature leaves from untransformed and transgenic plants were analysed. Fixation and immunogold labelled electron microscopy were performed as described by Vrekleij and Leunissen (1989) . Sections were first blocked, incubated for 1 h with a goat antihuman albumin polyclonal antibody (Nordic Immunology; dilution range from 1 : 1000 to 1 : 10 000) and then incubated for 2 h with a rabbit antigoat IgG secondary antibody conjugate to 10 nM gold diluted 1 : 40 in blocking solution. Sections were examined in a Zeiss EM 10 transmission electron microscope at 60 kV.
